Biostage, Inc. (BSTG)
Stock Price: $1.63 USD
0.00 (0.00%)
Updated Mar 5, 2021 10:47 AM EST - Market closed
| Market Cap | 15.30M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -5.44M |
| Shares Out | 8.86M |
| EPS (ttm) | -0.65 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | March 5 |
| Last Price | $1.63 |
| Previous Close | $1.63 |
| Change ($) | 0.00 |
| Change (%) | 0.00% |
| Day's Open | 1.63 |
| Day's Range | 1.63 - 1.63 |
| Day's Volume | 217 |
| 52-Week Range | 0.8 - 4.88 |
News
There are no news available yet.
About BSTG
Biostage, a biotechnology company, engages in developing bioengineered organ implants based on its Cellframe technology. The company's Cellframe technology comprises a biocompatible scaffold that is seeded with the recipient's own stem cells. It is developing its Cellframe technology to treat life-threatening conditions of the esophagus, bronchus, or trachea. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2007 and is headquarte... [Read more...]
| Industry Biotechnology | Founded 2007 |
| Stock Exchange OTCMKTS | Ticker Symbol BSTG |
Analyst Forecasts
The average 12-month stock price forecast for Biostage is 3.00, which is an increase of 84.05% from the latest price.
Price Target
$3.00
(84.05% upside)